Advertisement

help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

The Oncologist, Vol. 11, No. 7, 732-741, July 2006; doi:10.1634/theoncologist.11-7-732
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tascilar, M.
Right arrow Articles by Mathijssen, R. H. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tascilar, M.
Right arrow Articles by Mathijssen, R. H. J.

Clinical Pharmacology

Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence

Metin Tascilar, Floris A. de Jong, Jaap Verweij, Ron H. J. Mathijssen

Department of Medical Oncology, Erasmus University Medical Center Rotterdam—Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

Key Words. CAM • Herbs • Interactions • Cancer • Regulation • Internet

Correspondence: Ron H.J. Mathijssen, M.D., Ph.D., Erasmus University Medical Center Rotterdam—Daniel den Hoed Cancer Center, Department of Medical Oncology, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Telephone: 31-10-4391-112; Fax: 31-10-4391-053; e-mail: a.mathijssen{at}erasmusmc.nl

Nowadays, complementary and alternative medicine (CAM) is popular all over the world. Billions of dollars are spent in this booming business. For several reasons, young, female, educated, and higher socioeconomic class cancer patients, in particular, have shown interest in these agents. Unfortunately, besides direct (and sometimes serious) side effects, several CAM ingredients are capable of interfering with the metabolism of concurrently used drugs, which may render the therapeutic outcome of the subscribed drug unpredictable. In the case of anticancer drugs, with their usually narrow therapeutic window, this may have dramatic consequences and can lead to unacceptable toxicities in some cases or decreased therapeutic activity in others. Therefore, cancer patients should be warned for these possible interactions and be advised to discuss CAM use openly with their treating physician. The general concept that natural products are harmless should thus be changed into a more realistic and responsible attitude. A tightened legislation and regulation (including Internet advertising and sales) could play a crucial role in this awareness process. This should finally enable safe exploration of the potential advantageous aspects of CAM, while living with cancer.




This article has been cited by other articles:


Home page
Eur J Public HealthHome page
J. Van den Bulck and K. Custers
Belief in complementary and alternative medicine is related to age and paranormal beliefs in adults
Eur J Public Health, July 8, 2009; (2009) ckp104v1.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
R. H.J. Mathijssen, F. A. de Jong, W. J. Loos, J. M. van der Bol, J. Verweij, and A. Sparreboom
Flat-Fixed Dosing Versus Body Surface Area Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?
Oncologist, August 1, 2007; 12(8): 913 - 923.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
F. K. Engels, F. A. de Jong, A. Sparreboom, R. A. A. Mathot, W. J. Loos, J. J. E. M. Kitzen, P. de Bruijn, J. Verweij, and R. H. J. Mathijssen
Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel
Oncologist, March 1, 2007; 12(3): 291 - 300.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, August 12, 2006; 333(7563): 360 - 360.
[Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2006 by AlphaMed Press.
Advertisement